drugset / Trial / NCT02729935
Parecoxib for Treatment of Catheter Related Bladder Discomfort
RandomizedParallel-groupTriple-blindPrevention
Summary
Catheter-related bladder discomfort (CRBD) is defined as an urge to void or discomfort in the supra-pubic region; reported postoperatively in patients who have had urinary catheterization intra-operatively. In the present study, the investigators evaluated Parecoxib (P) for preventing CRBD in patients undergoing catheterization after transurethral resection of bladder tumor (TURBT).
Timeline
- Start
- 2016-03
- Primary completion
- 2016-05
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Parecoxib | Small molecule | 40 mg | Intravenous |
Indications
No indication recorded.